Status:
COMPLETED
Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema
Lead Sponsor:
Taizhou Hospital
Conditions:
Lymphedema
Eligibility:
All Genders
18-80 years
Brief Summary
Our aim was to identify optimal incision sites for LVA in extremity lymphedema that would result in the most effective drainage effect for reducing limb edema and enhancing patients' quality of life.
Detailed Description
designing the optimal incision sites and identifying functional lymphatic vessels imaging is crucial for success, primarily due to its efficacy in draining edematous lymphatic fluid and reducing swell...
Eligibility Criteria
Inclusion
- Aged 18-80 years; Lymphedema and swelling of the limbs for more than 3 months
- \-
Exclusion
- lipedema；myoedema
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT06188858
Start Date
January 1 2020
End Date
December 1 2023
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chong Liu
Zhejiang, China, 318000